triazolam has been researched along with midazolam in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (22.78) | 18.7374 |
1990's | 15 (18.99) | 18.2507 |
2000's | 27 (34.18) | 29.6817 |
2010's | 18 (22.78) | 24.3611 |
2020's | 1 (1.27) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Blanco, R; Coles, R; Kharasch, ED; Mitchell, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Baburin, I; Ebrahimi, SN; Eickmeier, E; Hamburger, M; Hering, S; Zaugg, J | 1 |
Baburin, I; Eigenmann, D; Hamburger, M; Hering, S; Khom, S; Zaugg, J | 1 |
Bracher, F; Fedorov, O; Filippakopoulos, P; Keller, M; Knapp, S; Morgenstern, O; Picaud, S; Wrobel, M | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Loeffler, PM | 1 |
Sanger, DJ; Zivkovic, B | 1 |
Amidon, GL; Goldberg, A; Lui, CY | 1 |
Battegay, R; Lieberherr, S; Scollo-Lavizzari, G | 1 |
Jones, CE; Martinez, LA; Merritt, GJ; Wians, FH | 1 |
Bircher, J; Crevoisier, C; Sostmann, H; Sostmann, HJ | 1 |
Gonzalez, FJ; Kronbach, T; Mathys, D; Meyer, UA; Umeno, M | 1 |
Bixler, EO; Jacoby, JA; Kales, A; Kales, JD; Soldatos, CR | 1 |
Christeller, S; Knüsel, R; Schelldorfer, K; Wehli, L | 1 |
Forgo, I | 1 |
Michenfelder, JD; Roald, OK; Stangland, K; Steen, PA | 1 |
Francescangeli, MA; Gentili, P; Omicini, A | 1 |
Christeller, S; Fabre, J; Hegelbach-Feller, DA; Tschopp, JM | 1 |
Forrest, P; Galletly, DC; Yee, P | 1 |
Hakkei, M; Kubota, A; Kuwahara, A; Nakamura, K | 1 |
Bixler, EO; Kales, A; Kales, JD; Soldatos, CR | 1 |
Acioli, A; Costa E Silva, JA; Ferreira, I; Jones Da Silva, C; Naylor, C | 1 |
Marias, J; Scherschlicht, R | 1 |
Eckert, M; Leishman, B; Schalch, E; Ziegler, WH | 1 |
Borbély, AA; Loepfe, M; Mattmann, P; Tobler, I | 1 |
Greenblatt, DJ; Shader, RI | 1 |
Borbély, AA | 1 |
Gandolfo, G; Gottesmann, C; Scherschlicht, R | 1 |
Finder, RL; McGirl, BE; Moore, PA; Stopperich, PS; Weyant, RJ | 1 |
Idänpään-Heikkilä, JJ; Mattila, MJ; Törnwall, M; Vanakoski, J | 1 |
Meier-Abt, PJ; Radovanovic, D; Wyss, PA | 1 |
Mattila, MJ; Seppälä, T; Vanakoski, J | 1 |
Dionne, R | 1 |
Cotreau, MM; Greenblatt, DJ; Perloff, MD; von Moltke, LL | 1 |
Ator, NA | 1 |
Bickel, WK; Smith, BJ | 1 |
Balian, JD; Flockhart, DA; Yuan, R | 1 |
Court, MH; Greenblatt, DJ; Kotegawa, T; Perloff, MD; Shader, RI; von Moltke, LL | 1 |
France, CP; Gerak, LR; Lelas, S | 1 |
Schrag, ML; Wienkers, LC | 1 |
Cantrell, VE; Eckstein, J; Hall, SD; Hamman, MA; Jones, DR; Ring, BJ; Ruterbories, K; Williams, JA; Wrighton, SA | 1 |
Feck, AS; Goodchild, JH; Silverman, MD | 1 |
Greenblatt, DJ; Patki, KC; Von Moltke, LL | 1 |
Chen, G; Greenblatt, DJ; Harmatz, JS; Jen, C; Kelley, CJ; LeDuc, BW; von Moltke, LL; Weemhoff, JL; Zinny, MA | 1 |
Cook, J; Debold, JF; Gourley, SL; Miczek, KA; Yin, W | 1 |
Masica, AL; Mayo, G; Wilkinson, GR | 1 |
France, CP; McMahon, LR | 1 |
Weaver, J | 1 |
Benet, LZ | 1 |
Baburin, I; Hering, S; Hohaus, A; Khom, S; Sieghart, W; Timin, EN | 1 |
Dickson, SJ; Irving, RC | 1 |
Lu, DP; Lu, WI | 1 |
Court, MH; Farkas, D; Greenblatt, DJ; Harmatz, JS; Oleson, LE; Zhao, Y; Zinny, MA | 1 |
Galetin, A; Hallifax, D; Houston, JB | 1 |
Baburin, I; Hering, S; Hohaus, A; Khom, S; Sieghart, W; Timin, E | 1 |
Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
Hanioka, N; Kuze, J; Morisaki, K; Mutoh, T; Nakura, H; Narimatsu, S; Takenaka, T | 1 |
Court, MH; Duan, SX; Greenblatt, DJ; Harmatz, JS; Parent, SJ; Venkatakrishnan, K; von Moltke, LL; Zhao, Y | 1 |
Weaver, JM | 1 |
Barter, ZE; Cubitt, HE; Howgate, EM; Rostami-Hodjegan, A; Yeo, KR | 1 |
Hanioka, N; Kuze, J; Mutoh, T; Narimatsu, S; Oda, N; Takenaka, T | 1 |
Srinivas, NR | 1 |
Imai, H; Iwao, M; Kotegawa, T; Nakano, S; Ohashi, K; Tsutsumi, K | 1 |
Baneyx, G; Iliadis, A; Lavé, T; Meille, C; Parrott, N | 1 |
Hamamura, S; Kamimura, H; Kato, K; Kawamura, A; Kazuki, Y; Nakada, N; Ohbuchi, M; Ohshita, H; Oshimura, M; Sato, K; Tateno, C; Usui, T | 1 |
Cook, JM; Fischer, BD; Namjoshi, OA; Platt, DM; Rallapalli, SK; Rowlett, JK | 1 |
Hasegawa, M; Tahara, H; Watanabe, M | 1 |
Fiorello, MG; Lee, HJ; Peeler, CE; Subramanian, ML; Villani, CM | 1 |
Gui, L; Hu, Y; Jia, W; Lan, K; Liu, C; Miao, J; Wang, C; Wei, W; Wu, Q; Zeng, W | 1 |
5 review(s) available for triazolam and midazolam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Data Collection; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Humans; Itraconazole; Ketoconazole; Midazolam; Triazolam | 1999 |
Benzodiazepine metabolism: an analytical perspective.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Azepines; Benzodiazepines; Bromazepam; Chromatography, High Pressure Liquid; Diazepam; Humans; Lorazepam; Mass Spectrometry; Midazolam; Triazolam | 2008 |
19 trial(s) available for triazolam and midazolam
Article | Year |
---|---|
Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir.
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Bupropion; Cross-Over Studies; Cytochrome P-450 CYP2B6; Female; HIV Protease Inhibitors; Humans; Liver; Male; Oxidoreductases, N-Demethylating; Ritonavir | 2008 |
Dose equivalence of midazolam and triazolam. A psychometric study based on flicker sensitivity, reaction time and digit symbol substitution test.
Topics: Adult; Double-Blind Method; Female; Flicker Fusion; Humans; Male; Midazolam; Perception; Psychometrics; Psychomotor Performance; Reaction Time; Self Concept; Sensory Thresholds; Triazolam | 1989 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
Comparison of midazolam and triazolam for residual effects.
Topics: Adult; Aircraft; Benzodiazepines; Circadian Rhythm; Double-Blind Method; Dreams; Humans; Male; Midazolam; Placebos; Psychomotor Performance; Random Allocation; Sleep; Triazolam; Work Schedule Tolerance | 1985 |
[Treatment of situation-related sleep disorders with midazolam and triazolam--a comparative study of athletes].
Topics: Adult; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Humans; Male; Midazolam; Random Allocation; Sleep Wake Disorders; Triazolam | 1986 |
[Double-blind parallel comparison of midazolam and triazolam in sleep disorders in the aged].
Topics: Age Factors; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Midazolam; Middle Aged; Sleep Wake Disorders; Triazolam | 1987 |
Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Dreams; Female; Humans; Male; Midazolam; Middle Aged; Random Allocation; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam | 1988 |
Placebo controlled comparison of midazolam, triazolam and diazepam as oral premedicants for outpatient anaesthesia.
Topics: Administration, Oral; Adult; Anesthesia Recovery Period; Anesthesia, General; Diazepam; Double-Blind Method; Humans; Midazolam; Middle Aged; Pain Measurement; Preanesthetic Medication; Random Allocation; Surveys and Questionnaires; Triazolam; Urologic Diseases | 1987 |
Midazolam and triazolam in out-patients: a double-blind comparison of hypnotic efficacy.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Midazolam; Sleep Initiation and Maintenance Disorders; Triazolam | 1983 |
Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Humans; Hydroxylation; Injections, Intravenous; Male; Memory; Midazolam; Psychomotor Performance; Reaction Time; Triazolam | 1983 |
Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Midazolam; Motor Activity; Psychomotor Performance; Sleep; Triazolam | 1983 |
Oral triazolam pretreatment for intravenous sedation.
Topics: Adolescent; Adult; Analysis of Variance; Anesthesia, Dental; Conscious Sedation; Dental Anxiety; Double-Blind Method; Female; Fentanyl; Humans; Male; Manifest Anxiety Scale; Methohexital; Midazolam; Pain Measurement; Preanesthetic Medication; Triazolam | 1993 |
Oral single doses of erythromycin and roxithromycin may increase the effects of midazolam on human performance.
Topics: Administration, Oral; Adult; Brain; Capsules; Double-Blind Method; Drug Combinations; Drug Synergism; Erythromycin; Female; Humans; Male; Midazolam; Psychomotor Performance; Roxithromycin; Triazolam | 1993 |
Grapefruit juice does not enhance the effects of midazolam and triazolam in man.
Topics: Adult; Beverages; Citrus; Cross-Over Studies; Double-Blind Method; Erythromycin; Female; Food-Drug Interactions; Humans; Hypnotics and Sedatives; Male; Midazolam; Psychomotor Performance; Triazolam | 1996 |
Flumazenil discrimination by humans under a two-response and a novel-response procedure.
Topics: Adolescent; Adult; Caffeine; Central Nervous System Stimulants; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Modulators; Humans; Male; Midazolam; Psychomotor Performance; Triazolam | 1999 |
Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Beverages; Biotransformation; Chromatography, Gas; Citrus paradisi; Cytochrome P-450 CYP3A; Female; Furocoumarins; Half-Life; Humans; Hypnotics and Sedatives; Isoenzymes; Kinetics; Liver; Male; Midazolam; Middle Aged; Oxidoreductases, N-Demethylating; Triazolam | 2003 |
In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Topics: Administration, Oral; Adult; Alprazolam; Anti-Anxiety Agents; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Biological Availability; Cytochrome P-450 CYP3A; Female; Humans; Male; Midazolam; Oxidoreductases, N-Demethylating; Triazolam | 2004 |
Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice.
Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Beverages; Citrus paradisi; Cross-Over Studies; Cytochrome P-450 CYP3A; Food-Drug Interactions; GABA Modulators; Humans; Injections, Intravenous; Lythraceae; Male; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Triazolam | 2007 |
Patient Satisfaction with Oral versus Intravenous Sedation for Cataract Surgery: A Randomized Clinical Trial.
Topics: Administration, Oral; Aged; Anesthetics, Intravenous; Anesthetics, Local; Conscious Sedation; Double-Blind Method; Eye Pain; Female; Humans; Hypnotics and Sedatives; Lens Implantation, Intraocular; Male; Midazolam; Middle Aged; Pain Measurement; Patient Satisfaction; Phacoemulsification; Prospective Studies; Triazolam | 2019 |
56 other study(ies) available for triazolam and midazolam
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Positive GABA(A) receptor modulators from Acorus calamus and structural analysis of (+)-dioxosarcoguaiacol by 1D and 2D NMR and molecular modeling.
Topics: Acorus; Animals; GABA Modulators; Mice; Molecular Structure; Oocytes; Receptors, GABA-A; Rhizome; Sesquiterpenes; Xenopus laevis | 2011 |
Identification and characterization of GABA(A) receptor modulatory diterpenes from Biota orientalis that decrease locomotor activity in mice.
Topics: Animals; Anti-Anxiety Agents; Diterpenes; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Male; Mice; Motor Activity; Oocytes; Receptors, GABA-A; Thuja; Xenopus laevis | 2011 |
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
Topics: Alprazolam; Benzazepines; Benzodiazepines; Cell Cycle Proteins; GABA Modulators; Humans; Midazolam; Models, Molecular; Nuclear Proteins; Protein Interaction Maps; Protein Structure, Tertiary; Transcription Factors | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Binding Sites; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Tolerance; Male; Midazolam; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Reinforcement, Psychology; Triazolam; Zolpidem | 1992 |
Intranasal absorption of flurazepam, midazolam, and triazolam in dogs.
Topics: Absorption; Administration, Intranasal; Administration, Oral; Animals; Chromatography, Gas; Dogs; Flurazepam; Intestinal Absorption; Male; Midazolam; Nasal Mucosa; Triazolam | 1991 |
[Confusional states following administration of short-acting benzodiazepines (midazolam/triazolam)].
Topics: Adult; Confusion; Female; Humans; Male; Memory Disorders; Midazolam; Middle Aged; Triazolam | 1991 |
Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
Topics: Alprazolam; Benzodiazepines; Benzophenones; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Immunoenzyme Techniques; Midazolam; Triazolam | 1989 |
Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
Topics: Animals; Autoantibodies; Cytochrome P-450 Enzyme System; DNA; Humans; Isoenzymes; Kinetics; Liver; Midazolam; Rats; Rats, Inbred Strains; Triazolam; Troleandomycin | 1989 |
The effects of triazolam on cerebral blood flow and metabolism in the dog.
Topics: Animals; Benzodiazepines; Brain; Brain Chemistry; Cerebrovascular Circulation; Diazepam; Dogs; Electroencephalography; Energy Metabolism; Female; Male; Midazolam; Oxygen Consumption; Triazolam | 1986 |
[Drug dependence tests on a new anesthesia inducer, midazolam].
Topics: Animals; Injections, Intravenous; Macaca fascicularis; Male; Midazolam; Pentobarbital; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1986 |
Early morning insomnia with rapidly eliminated benzodiazepines.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Half-Life; Humans; Midazolam; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam | 1983 |
Effects of oral and intravenous midazolam, triazolam and flunitrazepam on the sleep-wakefulness cycle of rabbits.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Benzodiazepines; Electroencephalography; Electromyography; Flunitrazepam; Injections, Intravenous; Male; Midazolam; Rabbits; Sleep; Sleep, REM; Triazolam; Wakefulness | 1983 |
Short half-life benzodiazepines.
Topics: Anti-Anxiety Agents; Azepines; Benzodiazepines; Half-Life; Humans; Kinetics; Midazolam; Triazolam | 1984 |
Ambulatory motor activity monitoring to study the timecourse of hypnotic action.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flunitrazepam; Flurazepam; Humans; Hypnotics and Sedatives; Midazolam; Motor Activity; Sleep; Temazepam; Time Factors; Triazolam | 1984 |
Benzodiazepines promote the intermediate stage at the expense of paradoxical sleep in the rat.
Topics: Animals; Anti-Anxiety Agents; Diazepam; Electroencephalography; Epilepsy; Eye Movements; Heart Rate; Male; Midazolam; Rats; Rats, Inbred Strains; Rats, Wistar; Sleep Stages; Sleep, REM; Species Specificity; Theta Rhythm; Triazolam | 1994 |
[Acute overdose of Zolpidem (Stilnox)].
Topics: Adolescent; Adult; Aged; Antidotes; Coma; Drug Overdose; Female; Flumazenil; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Pyridines; Retrospective Studies; Triazolam; Zolpidem | 1996 |
Oral sedation.
Topics: Administration, Oral; Algorithms; Anesthesia, Dental; Anti-Anxiety Agents; Chloral Hydrate; Conscious Sedation; Dental Anxiety; Diazepam; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypnotics and Sedatives; Midazolam; Mutagens; Premedication; Triazolam | 1998 |
Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Blotting, Western; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Mice; Microsomes, Liver; Midazolam; Oxidoreductases, N-Demethylating; Triazolam | 1999 |
High-dose discrimination training with midazolam: context determines generalization profile.
Topics: Animals; Anti-Anxiety Agents; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Generalization, Psychological; Hypnotics and Sedatives; Male; Midazolam; Pentobarbital; Rats; Rats, Long-Evans; Time Factors; Triazolam | 1999 |
Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Topics: Animals; Antibodies; Aryl Hydrocarbon Hydroxylases; Biotransformation; Blotting, Western; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Humans; Immunochemistry; In Vitro Techniques; Inhibitory Concentration 50; Ketoconazole; Mice; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Protein Isoforms; Species Specificity; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Triazolam | 2000 |
Discriminative-stimulus effects of triazolam and midazolam in rhesus monkeys.
Topics: Animals; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Modulators; Generalization, Stimulus; Hypnotics and Sedatives; Macaca mulatta; Male; Midazolam; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule; Triazolam | 1999 |
Covalent alteration of the CYP3A4 active site: evidence for multiple substrate binding domains.
Topics: Binding Sites; Binding, Competitive; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Kinetics; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Protein Structure, Tertiary; Substrate Specificity; Testosterone; Triazolam | 2001 |
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Topics: Alprazolam; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clarithromycin; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes b5; Diltiazem; Estradiol; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Midazolam; Nifedipine; Tamoxifen; Testosterone; Triazolam | 2002 |
Anxiolysis in general dental practice.
Topics: Acetamides; Adjuvants, Anesthesia; Anesthesia, Dental; Anesthetics, Inhalation; Anti-Anxiety Agents; Clinical Protocols; Conscious Sedation; Dental Anxiety; Diazepam; GABA Modulators; General Practice, Dental; Humans; Hydroxyzine; Hypnotics and Sedatives; Lorazepam; Midazolam; Nitrous Oxide; Pyrimidines; Triazolam | 2003 |
In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.
Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Ketoconazole; Microsomes, Liver; Midazolam; Nifedipine; Recombinant Proteins; Testosterone; Triazolam | 2003 |
Benzodiazepines and heightened aggressive behavior in rats: reduction by GABA(A)/alpha(1) receptor antagonists.
Topics: Aggression; Agonistic Behavior; Animals; Arousal; Dose-Response Relationship, Drug; GABA Modulators; Hypnotics and Sedatives; Male; Midazolam; Motor Activity; Rats; Rats, Long-Evans; Receptors, GABA-A; Triazolam | 2005 |
Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethanol; GABA Modulators; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Injections, Subcutaneous; Isoxazoles; Macaca mulatta; Male; Midazolam; Pentobarbital; Pregnanolone; Receptors, GABA-A; Time Factors; Triazolam; Women | 2005 |
Conscious sedation in dental practice in the USA. An update on drugs, techniques and monitoring.
Topics: Administration, Oral; Anesthesia Recovery Period; Anesthesia, Dental; Conscious Sedation; Emergency Treatment; Fentanyl; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Injections, Intravenous; Ketamine; Midazolam; Monitoring, Intraoperative; Monitoring, Physiologic; Triazolam; United States | 2004 |
There are no useful CYP3A probes that quantitatively predict the in vivo kinetics of other CYP3A substrates and no expectation that one will be found.
Topics: Alprazolam; Benzodiazepines; Biopharmaceutics; Chemistry, Pharmaceutical; Cytochrome P-450 CYP3A; Drug Design; Humans; Kinetics; Midazolam; Molecular Probes; Protein Binding; Solubility; Triazolam | 2005 |
Pharmacological properties of GABAA receptors containing gamma1 subunits.
Topics: Animals; Azepines; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Midazolam; Oocytes; Protein Subunits; Pyrazoles; Receptors, GABA-A; Triazolam; Xenopus laevis | 2006 |
The detection of sedatives in hair and nail samples using tandem LC-MS-MS.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam | 2007 |
Practical oral sedation in dentistry. Part II--Clinical application of various oral sedatives and discussion.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Anesthesia, Dental; Child; Child, Preschool; Chloral Hydrate; Conscious Sedation; Diazepam; Fentanyl; Humans; Hypnotics and Sedatives; Meperidine; Midazolam; Nausea; Promethazine; Triazolam; Vomiting | 2006 |
Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines.
Topics: Alprazolam; Benzodiazepines; Cell Survival; Cells, Cultured; Cryopreservation; Cytochrome P-450 CYP3A; Diazepam; Flunitrazepam; Hepatocytes; Humans; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Substrate Specificity; Triazolam | 2008 |
Estimating the efficiency of benzodiazepines on GABA(A) receptors comprising gamma1 or gamma2 subunits.
Topics: Animals; Azepines; Benzodiazepines; Dose-Response Relationship, Drug; Female; GABA Modulators; Midazolam; Oocytes; Patch-Clamp Techniques; Protein Subunits; Receptors, GABA-A; Regression Analysis; Triazolam; Xenopus laevis | 2008 |
Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice.
Topics: Administration, Oral; Alprazolam; Animals; Benzodiazepines; Biological Availability; Catheterization; Intestinal Mucosa; Jugular Veins; Liver; Male; Mice; Mice, Inbred BALB C; Midazolam; Portal Vein; Rats; Rats, Sprague-Dawley; Triazolam | 2009 |
Mechanism of cytochrome P450-3A inhibition by ketoconazole.
Topics: Adult; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Inhibitory Concentration 50; Ketoconazole; Male; Microsomes, Liver; Midazolam; Middle Aged; Nifedipine; Testosterone; Triazolam; Young Adult | 2011 |
The fallacy of a lifesaving sublingual injection of flumazenil.
Topics: Anesthesia Recovery Period; Antidotes; Benzodiazepines; Conscious Sedation; Drug Overdose; Flumazenil; GABA Modulators; Humans; Hypnotics and Sedatives; Hypoxia, Brain; Injections; Injections, Intramuscular; Injections, Intravenous; Midazolam; Receptors, GABA-A; Respiration, Artificial; Triazolam | 2011 |
Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model.
Topics: Alprazolam; Benzodiazepines; Cytochrome P-450 CYP3A; Humans; Kinetics; Liver; Metabolic Clearance Rate; Midazolam; Triazolam | 2011 |
Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam.
Topics: Animals; Beverages; Citrus paradisi; Cytochrome P-450 CYP3A; Food-Drug Interactions; Humans; Hydroxylation; Kinetics; Male; Mice; Mice, Inbred BALB C; Microsomes; Midazolam; Models, Animal; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley; Species Specificity; Tandem Mass Spectrometry; Triazolam | 2013 |
Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence.
Topics: Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Beverages; Buspirone; Caco-2 Cells; Calcium Channel Blockers; Carbamazepine; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Evaluation, Preclinical; Drug Interactions; Flurbiprofen; Food-Drug Interactions; Humans; Hypnotics and Sedatives; Hypoglycemic Agents; Lythraceae; Midazolam; Nitrendipine; Tolbutamide; Triazolam | 2013 |
[Determination of triazolam and midazolam in human plasma using gas chromatography with microelectron capture detection for clinical application].
Topics: Chromatography, Gas; Electrons; Humans; Midazolam; Solvents; Triazolam | 2014 |
Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administration.
Topics: Alfentanil; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Hepatocytes; Humans; Midazolam; Models, Biological; Nifedipine; Rifampin; Tissue Distribution; Triazolam | 2014 |
Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver.
Topics: Albumins; Animals; Aryl Hydrocarbon Hydroxylases; Chimera; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Glucuronosyltransferase; Hepatocytes; Humans; Intestinal Mucosa; Isoenzymes; Liver; Mice; Mice, Knockout; Mice, SCID; Mice, Transgenic; Microsomes, Liver; Midazolam; RNA, Messenger; Steroid Hydroxylases; Triazolam; Urokinase-Type Plasminogen Activator | 2015 |
Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis.
Topics: Animals; Benzodiazepines; Dose-Response Relationship, Drug; GABA Modulators; Humans; Macaca mulatta; Male; Midazolam; Reaction Time; Receptors, GABA-A; Reinforcement Schedule; Self Administration; Triazolam | 2016 |
A comparative study for detecting CYP3A induction by CYP3A probe drugs and endogenous markers in cynomolgus monkeys.
Topics: Alprazolam; Animals; Area Under Curve; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Dose-Response Relationship, Drug; Drug Interactions; Hydrocortisone; Hydroxycholesterols; Macaca fascicularis; Male; Midazolam; Rifampin; Triazolam | 2019 |
Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs.
Topics: Alprazolam; Animals; Benzodiazepines; Cytochrome P-450 CYP3A; Deoxycholic Acid; Dogs; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Midazolam; Protein Isoforms; Species Specificity; Steroids; Triazolam | 2022 |